1 2318 174 TREATING MAJOR DEPRESSION WITH YOGA: A PROSPECTIVE, RANDOMIZED, CONTROLLED PILOT TRIAL. BACKGROUND: CONVENTIONAL PHARMACOTHERAPIES AND PSYCHOTHERAPIES FOR MAJOR DEPRESSION ARE ASSOCIATED WITH LIMITED ADHERENCE TO CARE AND RELATIVELY LOW REMISSION RATES. YOGA MAY OFFER AN ALTERNATIVE TREATMENT OPTION, BUT RIGOROUS STUDIES ARE FEW. THIS RANDOMIZED CONTROLLED TRIAL WITH BLINDED OUTCOME ASSESSORS EXAMINED AN 8-WEEK HATHA YOGA INTERVENTION AS MONO-THERAPY FOR MILD-TO-MODERATE MAJOR DEPRESSION. METHODS: INVESTIGATORS RECRUITED 38 ADULTS IN SAN FRANCISCO MEETING CRITERIA FOR MAJOR DEPRESSION OF MILD-TO-MODERATE SEVERITY, PER STRUCTURED PSYCHIATRIC INTERVIEW AND SCORES OF 14-28 ON BECK DEPRESSION INVENTORY-II (BDI). AT SCREENING, INDIVIDUALS ENGAGED IN PSYCHOTHERAPY, ANTIDEPRESSANT PHARMACOTHERAPY, HERBAL OR NUTRACEUTICAL MOOD THERAPIES, OR MIND-BODY PRACTICES WERE EXCLUDED. PARTICIPANTS WERE 68% FEMALE, WITH MEAN AGE 43.4 YEARS (SD = 14.8, RANGE = 22-72), AND MEAN BDI SCORE 22.4 (SD = 4.5). TWENTY PARTICIPANTS WERE RANDOMIZED TO 90-MINUTE HATHA YOGA PRACTICE GROUPS TWICE WEEKLY FOR 8 WEEKS. EIGHTEEN PARTICIPANTS WERE RANDOMIZED TO 90-MINUTE ATTENTION CONTROL EDUCATION GROUPS TWICE WEEKLY FOR 8 WEEKS. CERTIFIED YOGA INSTRUCTORS DELIVERED BOTH INTERVENTIONS AT A UNIVERSITY CLINIC. PRIMARY OUTCOME WAS DEPRESSION SEVERITY, MEASURED BY BDI SCORES EVERY 2 WEEKS FROM BASELINE TO 8 WEEKS. SECONDARY OUTCOMES WERE SELF-EFFICACY AND SELF-ESTEEM, MEASURED BY SCORES ON THE GENERAL SELF-EFFICACY SCALE (GSES) AND ROSENBERG SELF-ESTEEM SCALE (RSES) AT BASELINE AND AT 8 WEEKS. RESULTS: IN INTENT-TO-TREAT ANALYSIS, YOGA PARTICIPANTS EXHIBITED SIGNIFICANTLY GREATER 8-WEEK DECLINE IN BDI SCORES THAN CONTROLS (P-VALUE = 0.034). IN SUB-ANALYSES OF PARTICIPANTS COMPLETING FINAL 8-WEEK MEASURES, YOGA PARTICIPANTS WERE MORE LIKELY TO ACHIEVE REMISSION, DEFINED PER FINAL BDI SCORE .05) OR ANXIETY (F = 2.7, P > .05). CONCLUSIONS/IMPLICATIONS FOR PRACTICE: THE 8-WEEK YOGA EXERCISE PROGRAM DEVELOPED IN THIS STUDY EFFECTIVELY REDUCED FATIGUE IN PATIENTS WITH BREAST CANCER BUT DID NOT REDUCE DEPRESSION OR ANXIETY. ONCOLOGY NURSES SHOULD STRENGTHEN THEIR CLINICAL HEALTH EDUCATION AND APPLY YOGA TO REDUCE THE FATIGUE EXPERIENCED BY PATIENTS WITH BREAST CANCER WHO UNDERGO ADJUVANT CHEMOTHERAPY. 2014 12 1072 54 EFFECTS OF YOGA ON OXIDATIVE STRESS, MOTOR FUNCTION, AND NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE: A PILOT RANDOMIZED CONTROLLED TRIAL. OBJECTIVE: TO EXAMINE THE FEASIBILITY, ACCEPTABILITY, AND PRELIMINARY EFFECTS OF HATHA YOGA ON OXIDATIVE STRESS, MOTOR FUNCTION, AND NON-MOTOR SYMPTOMS AMONG INDIVIDUALS WITH PARKINSON'S DISEASE (PD). METHODS: THE STUDY HAS A PILOT RANDOMIZED CONTROLLED TRIAL DESIGN WITH TWO ARMS: AN IMMEDIATE TREATMENT GROUP AND A WAIT-LIST CONTROL GROUP. THE YOGA-FOR-PD PROGRAM WAS IMPLEMENTED VIA TWICE WEEKLY 60-MIN GROUP-BASED CLASSES FOR 12 WEEKS. PARTICIPANTS WERE ASSESSED AT BASELINE, 12 WEEKS, AND 6 MONTHS POST-INTERVENTION. OUTCOME MEASURES INCLUDED OXIDATIVE STRESS, MOTOR FUNCTION, PHYSICAL ACTIVITY, COGNITIVE FUNCTION, SLEEP QUALITY, AND QUALITY OF LIFE. DATA ON PROGRAM ACCEPTABILITY AND YOGA ADHERENCE WERE COLLECTED DURING THE INTERVENTION AND AT 6 MONTHS POST-INTERVENTION. RESULTS: PARTICIPANTS (N = 20) HAD A MEAN AGE OF 63 YEARS (SD 8, RANGE 49-75) AND DISEASE DURATION 4.8 YEARS (SD 2.9, RANGE 1-13). ALL PARTICIPANTS HAD MILD-MODERATE DISEASE SEVERITY; 18 (90%) WERE ON DOPAMINERGIC MEDICATIONS. SEVENTEEN PARTICIPANTS (85%) ATTENDED AT LEAST 75% OF THE CLASSES AND 4 (20%) ATTENDED ALL CLASSES. MOST PARTICIPANTS (N = 17) REPORTED THEY "DEFINITELY ENJOYED" THE INTERVENTION PROGRAM. NO ADVERSE EVENTS WERE REPORTED. AT 12 WEEKS, THERE WERE NO MAJOR DIFFERENCES IN BLOOD OXIDATIVE STRESS MARKERS BETWEEN THE TWO GROUPS. MOTOR FUNCTION BASED ON THE UNIFIED PARKINSON'S DISEASE RATING SCALE WAS BETTER IN THE TREATMENT GROUP, BUT THEIR SCORES ON SLEEP AND OUTLOOK IN PARKINSON'S DISEASE QUALITY OF LIFE (PDQUALIF) SCALE AND THE PHYSICAL ACTIVITY LEVELS BASED ON THE LONGITUDINAL AGING STUDY AMSTERDAM PHYSICAL ACTIVITY QUESTIONNAIRE WERE WORSE THAN THOSE OF THE CONTROL GROUP. IN WITHIN-GROUP COMPARISONS, MOTOR FUNCTION, COGNITIVE FUNCTION, AND CATALASE IMPROVED BUT THREE PDQUALIF DOMAINS (SOCIAL AND ROLE FUNCTION, SLEEP, AND OUTLOOK) AND PHYSICAL ACTIVITY LEVEL WORSENED BY THE END OF THE YOGA INTERVENTION PROGRAM COMPARED TO BASELINE. THE RESPONSE RATE FOR THE 6-MONTH FOLLOW-UP SURVEY WAS 74% (N = 14) WITH SIX PARTICIPANTS (43%) WHO SIGNED UP FOR A YOGA CLASS AND FOUR (29%) WHO PRACTICED IT INDEPENDENTLY. HEALTH PROBLEMS WERE THE MAIN BARRIER TO YOGA PRACTICE. CONCLUSION: YOGA IS FEASIBLE AND ACCEPTABLE AND MAY SERVE AS A COMPLEMENTARY METHOD FOR IMPROVING MOTOR FUNCTION IN PD. FURTHER RESEARCH USING A LARGER SAMPLE SIZE IS NEEDED TO DETERMINE ITS IMPACT ON OXIDATIVE STRESS AND NON-MOTOR SYMPTOMS. TRIAL REGISTRATION: CLINICALTRIALS.GOV REGISTRATION NUMBER: NCT02509610031. 2018 13 1542 40 KRIYA YOGA IN PATIENTS WITH DEPRESSIVE DISORDERS: A PILOT STUDY. BACKGROUND AND OBJECTIVES DESPITE THE EASY ACCEPTABILITY AND HOLISTIC NATURE OF KRIYA YOGA, THERE ARE NO STUDIES EVALUATING THE ROLE OF KRIYA YOGA INTERVENTION ON DEPRESSION. THE OBJECTIVE OF THE CURRENT STUDY WAS TO ASSESS THE FEASIBILITY AND EFFECT OF ADJUNCTIVE KRIYA YOGA ON DEPRESSION. METHODS PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO OPTED FOR KRIYA YOGA WERE RECRUITED INTO THE INTERVENTION GROUP (ADJUNCTIVE KRIYA YOGA) AND THOSE ON PSYCHOTROPIC MEDICATION ALONE WERE ENROLLED INTO THE CONTROL GROUP. THE HAMILTON DEPRESSION RATING SCALE (HDRS) MEASUREMENTS WERE RECORDED AT BASELINE, END OF 2, 4, AND 8 WEEKS. RESULTS HDRS SCORES OF THE INTERVENTION GROUP ( N = 29) WERE FOUND TO BE SIGNIFICANTLY LESSER THAN THAT OF THE CONTROL GROUP ( N = 52) BY THE END OF 2, 4, AND 8 WEEKS. THE REMISSION RATE WAS ALSO SIGNIFICANTLY GREATER IN THE INTERVENTION GROUP. CONCLUSION KRIYA YOGA INTERVENTION WAS FOUND TO BE FEASIBLE, AS WELL AS IMPROVED THE SEVERITY OF DEPRESSION. 2021 14 1527 38 IYENGAR YOGA FOR DISTRESSED WOMEN: A 3-ARMED RANDOMIZED CONTROLLED TRIAL. DISTRESS IS AN INCREASING PUBLIC HEALTH PROBLEM. WE AIMED TO INVESTIGATE THE EFFECTS OF AN IYENGAR YOGA PROGRAM ON PERCEIVED STRESS AND PSYCHOLOGICAL OUTCOMES IN DISTRESSED WOMEN AND EVALUATED A POTENTIAL DOSE-EFFECT RELATIONSHIP. SEVENTY-TWO FEMALE DISTRESSED SUBJECTS WERE INCLUDED INTO A 3-ARMED RANDOMIZED CONTROLLED TRIAL AND ALLOCATED TO YOGA GROUP 1 (N = 24) WITH TWELVE 90 MIN SESSIONS OVER 3 MONTHS, YOGA GROUP 2 (N = 24) WITH 24 SESSIONS OVER 3 MONTHS, OR A WAITING LIST CONTROL GROUP (N = 24). THE PRIMARY OUTCOME WAS STRESS PERCEPTION, MEASURED BY COHEN STRESS SCALE; SECONDARY OUTCOMES INCLUDED STATE TRAIT ANXIETY, DEPRESSION, PSYCHOLOGICAL AND PHYSICAL QUALITY OF LIFE (QOL), PROFILE OF MOOD STATES, WELL BEING, AND BODILY COMPLAINTS. AFTER THREE MONTHS, WOMEN IN THE YOGA GROUPS SHOWED SIGNIFICANT IMPROVEMENTS IN PERCEIVED STRESS (P = 0.003), STATE TRAIT ANXIETY (P = 0.021 AND P = 0.003), DEPRESSION (P = 0.008), PSYCHOLOGICAL QOL (P = 0.012), MOOD STATES BEING (P = 0.007), AND BODILY COMPLAINTS WELL(P = 0.012) WHEN COMPARED TO CONTROLS. BOTH YOGA PROGRAMS WERE SIMILARLY EFFECTIVE FOR THESE OUTCOMES; HOWEVER, COMPLIANCE WAS BETTER IN THE GROUP WITH FEWER SESSIONS (YOGA GROUP 1). DOSE EFFECTS WERE SEEN ONLY IN THE ANALYSIS OF GROUP-INDEPENDENT EFFECTS FOR BACK PAIN, ANXIETY, AND DEPRESSION. THESE FINDINGS SUGGEST THAT IYENGAR YOGA EFFECTIVELY REDUCES DISTRESS AND IMPROVES RELATED PSYCHOLOGICAL AND PHYSICAL OUTCOMES. FURTHERMORE, ATTENDING TWICE-WEEKLY YOGA CLASSES WAS NOT SUPERIOR TO ONCE-WEEKLY CLASSES, AS A RESULT OF LIMITED COMPLIANCE IN THE TWICE-WEEKLY GROUP. 2012 15 1483 39 INTEGRATING YOGA WITH PSYCHOLOGICAL GROUP-TREATMENT FOR MIXED DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE: AN EXPLORATIVE PILOT STUDY. BACKGROUND AND PURPOSE: YOGA HAS SHOWN PROMISE AS A TREATMENT FOR DEPRESSION AND ANXIETY. THE PRESENT PILOT STUDY INVESTIGATED THE FEASIBILITY OF AN EIGHT-WEEK GROUPTREATMENT INTEGRATING EMOTION-FOCUSED PSYCHOEDUCATION, COMPASSION-FOCUSED THERAPY, AND VIRYA YOGA FOR DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE. MATERIALS AND METHODS: PATIENTS SEEKING TREATMENT FOR DEPRESSION AND ANXIETY IN A PRIMARY HEALTHCARE CENTRE COMPLETED EITHER AN INTEGRATIVE GROUP-TREATMENT (N = 14) OR TREATMENT AS USUAL (TAU, N = 17). OUTCOME MEASURES WERE ANALYSED PRE- AND POSTTREATMENT. CORRELATIONS IN THE INTERVENTION GROUP WERE INVESTIGATED BETWEEN TREATMENT OUTCOMES AND AMOUNT OF YOGA PRACTICE BETWEEN SESSIONS. RESULTS: LARGE WITHIN-GROUP EFFECT SIZES ON ALL OUTCOME MEASURES WERE FOUND AT POSTTREATMENT. SYMPTOM REDUCTION DID NOT DIFFER BETWEEN GROUPS (P = 0.155). IMPROVEMENT IN ALEXITHYMIA CORRELATED SIGNIFICANTLY (P < 0.05) WITH AMOUNT OF YOGA PRACTICE BETWEEN SESSIONS. CONCLUSION: INTEGRATING YOGA WITH A PSYCHOLOGICAL GROUP-TREATMENT IS A SOMEWHAT FEASIBLE APPROACH TO TREATMENT FOR DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE. 2020 16 948 47 EFFECTS OF A 6 WEEK YOGA INTERVENTION ON EXECUTIVE FUNCTIONING IN WOMEN SCREENING POSITIVE FOR ADULT ADHD: A PILOT STUDY. PURPOSE: LITTLE IS KNOWN ABOUT THE EFFECTS OF YOGA TRAINING IN ADULTS WITH ADHD SYMPTOMS. THIS PILOT STUDY SOUGHT TO DETERMINE THE FEASIBILITY AND SELECTED PSYCHOLOGICAL EFFECTS OF 6 WEEKS OF YOGA TRAINING IN WOMEN SCREENING POSITIVE FOR ADULT ADHD COMPARED TO A WAIT-LIST CONTROL GROUP. METHODS: A RANDOMIZED TRIAL WAS CONDUCTED WITH 32 ADULT WOMEN (18-24 YEARS) WHO VOLUNTEERED AFTER SCREENING POSITIVE FOR ADULT ADHD AS ASSESSED BY THE ADULT ADHD SELF-REPORT SCALE (ASRS). PARTICIPANTS WERE RANDOMIZED TO 6 WEEKS OF BIKRAM YOGA TRAINING OR TO A WAIT-LIST CONTROL GROUP. THE YOGA INTERVENTION CONSISTED OF TWO 90-MIN CLASSES PER WEEK. MULTILEVEL MODELS WERE USED TO TEST HYPOTHESIZED INTERACTIONS OF YOGA-INDUCED IMPROVEMENTS COMPARED TO CONTROLS ACROSS TIME (BASELINE, 3 WEEKS, AND 6 WEEKS). THE PRIMARY OUTCOMES ASSESSED INHIBITORY CONTROL, COGNITIVE FLEXIBILITY AND WORKING MEMORY USING THE NIH TOOLBOX. SEPARATE MODELS WITH TRAIT MINDFULNESS, TRAIT ANXIETY AND EXPECTATIONS FOR CHANGE IN EITHER ATTENTION OR WORKING MEMORY AS COVARIATES TESTED WHETHER THESE VARIABLES MEDIATED THE CHANGES IN THE THREE MEASURES OF EXECUTIVE FUNCTION. SECONDARY OUTCOMES INCLUDED MOOD, PERCEIVED FUNCTIONAL IMPAIRMENT AND MOTIVATION FOR, AND HYPERACTIVITY DURING, THE COGNITIVE TESTS. RESULTS: NO ADVERSE EVENTS WERE OBSERVED. ATTENDANCE AVERAGED 91.7% AMONG THE 69% OF THE SAMPLE THAT DID NOT DROPOUT. NO SIGNIFICANT GROUP X TIME INTERACTIONS WERE FOUND FOR ANY OF THE PSYCHOLOGICAL OUTCOMES AND THE NULL EXECUTIVE FUNCTION FINDINGS WERE UNCHANGED WHEN INCLUDING THE COVARIATES. CONCLUSION: SIX-WEEKS OF YOGA TRAINING TWICE PER WEEK IS POTENTIALLY FEASIBLE FOR WOMEN EXPERIENCING ADHD SYMPTOMS, BUT AN EXERCISE STIMULUS OF THIS DURATION AND MAGNITUDE YIELDS NO BENEFICIAL COGNITIVE OR MOOD OUTCOMES. 2022 17 1902 45 RESTORATIVE YOGA IN ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED, CONTROLLED PILOT TRIAL. BACKGROUND: METABOLIC SYNDROME INCREASES THE RISK OF DIABETES AND CARDIOVASCULAR DISEASE. YOGA IMPROVES SOME METABOLIC PARAMETERS, BUT IT HAS NOT BEEN STUDIED IN PERSONS WITH METABOLIC SYNDROME. WE CONDUCTED A RANDOMIZED CONTROLLED PILOT TRIAL TO DETERMINE WHETHER A RESTORATIVE YOGA INTERVENTION WAS FEASIBLE AND ACCEPTABLE IN UNDERACTIVE, OVERWEIGHT ADULTS WITH METABOLIC SYNDROME. METHODS: TWENTY SIX UNDERACTIVE, OVERWEIGHT ADULT MEN AND WOMEN WITH METABOLIC SYNDROME WERE RANDOMIZED TO ATTEND 15 YOGA SESSIONS OF 90 MINUTES EACH OVER 10 WEEKS OR TO A WAIT-LIST CONTROL GROUP. FEASIBILITY WAS MEASURED BY RECRUITMENT RATES, SUBJECT RETENTION, AND ADHERENCE. ACCEPTABILITY WAS ASSESSED BY INTERVIEW AND QUESTIONNAIRES. CHANGES IN METABOLIC OUTCOMES AND QUESTIONNAIRE MEASURES FROM BASELINE TO WEEK 10 WERE CALCULATED. RESULTS: A TOTAL OF 280 PEOPLE WERE SCREENED BY PHONE, AND 93 WITH HIGH LIKELIHOOD OF METABOLIC SYNDROME WERE INVITED TO A SCREENING VISIT. OF THE 68 WHO ATTENDED SCREENING VISITS, 26 (38%) WERE RANDOMIZED, AND 24 (92%) COMPLETED THE TRIAL. ATTENDANCE AT YOGA CLASSES AND ADHERENCE TO HOME PRACTICE EXCEEDED OUR GOALS. IN THE YOGA GROUP, ALL PARTICIPANTS GAVE THE STUDY THE HIGHEST POSSIBLE SATISFACTION RATING, AND THE MAJORITY (87%) FELT THAT THE YOGA POSES WERE EASY TO PERFORM. THERE WAS TREND TO REDUCED BLOOD PRESSURE (P = 0.07), A SIGNIFICANT INCREASE IN ENERGY LEVEL (P < 0.009), AND TRENDS TO IMPROVEMENT IN WELL-BEING (P < 0.12) AND STRESS (P < 0.22) IN THE YOGA VERSUS CONTROL GROUP. CONCLUSIONS: RESTORATIVE YOGA WAS A FEASIBLE AND ACCEPTABLE INTERVENTION IN OVERWEIGHT ADULTS WITH METABOLIC SYNDROME. THE EFFICACY OF YOGA FOR IMPROVING METABOLIC PARAMETERS IN THIS POPULATION SHOULD BE EXPLORED IN A LARGER RANDOMIZED CONTROLLED TRIAL. 2008 18 159 37 A RANDOMISED COMPARATIVE TRIAL OF YOGA AND RELAXATION TO REDUCE STRESS AND ANXIETY. OBJECTIVE: TO COMPARE YOGA AND RELAXATION AS TREATMENT MODALITIES AT 10 AND 16 WEEKS FROM STUDY BASELINE TO DETERMINE IF EITHER OF MODALITY REDUCES SUBJECT STRESS, ANXIETY, BLOOD PRESSURE AND IMPROVE QUALITY OF LIFE. DESIGN: A RANDOMISED COMPARATIVE TRIAL WAS UNDERTAKEN COMPARING YOGA WITH RELAXATION. PARTICIPANTS: ONE HUNDRED AND THIRTY-ONE SUBJECTS WITH MILD TO MODERATE LEVELS OF STRESS WERE RECRUITED FROM THE COMMUNITY IN SOUTH AUSTRALIA. INTERVENTIONS: TEN WEEKLY 1- H SESSIONS OF RELAXATION OR HATHA YOGA. MAIN OUTCOME MEASURES: CHANGES IN THE STATE TRAIT PERSONALITY INVENTORY SUB-SCALE ANXIETY, GENERAL HEALTH QUESTIONNAIRE AND THE SHORT FORM-36. RESULTS: FOLLOWING THE 10 WEEK INTERVENTION STRESS, ANXIETY AND QUALITY OF LIFE SCORES IMPROVED OVER TIME. YOGA WAS FOUND TO BE AS EFFECTIVE AS RELAXATION IN REDUCING STRESS, ANXIETY AND IMPROVING HEALTH STATUS ON SEVEN DOMAINS OF THE SF-36. YOGA WAS MORE EFFECTIVE THAN RELAXATION IN IMPROVING MENTAL HEALTH. AT THE END OF THE 6 WEEK FOLLOW-UP PERIOD THERE WERE NO DIFFERENCES BETWEEN GROUPS IN LEVELS OF STRESS, ANXIETY AND ON FIVE DOMAINS OF THE SF-36. VITALITY, SOCIAL FUNCTION AND MENTAL HEALTH SCORES ON THE SF-36 WERE HIGHER IN THE RELAXATION GROUP DURING THE FOLLOW-UP PERIOD. CONCLUSION: YOGA APPEARS TO PROVIDE A COMPARABLE IMPROVEMENT IN STRESS, ANXIETY AND HEALTH STATUS COMPARED TO RELAXATION. 2007 19 187 50 A RANDOMIZED PREFERENCE TRIAL COMPARING COGNITIVE-BEHAVIORAL THERAPY AND YOGA FOR THE TREATMENT OF LATE-LIFE WORRY: EXAMINATION OF IMPACT ON DEPRESSION, GENERALIZED ANXIETY, FATIGUE, PAIN, SOCIAL PARTICIPATION, AND PHYSICAL FUNCTION. BACKGROUND: DEPRESSION, GENERALIZED ANXIETY, FATIGUE, DIMINISHED PHYSICAL FUNCTION, REDUCED SOCIAL PARTICIPATION, AND PAIN ARE COMMON FOR MANY OLDER ADULTS AND NEGATIVELY IMPACT QUALITY OF LIFE. THE PURPOSE OF THE OVERALL TRIAL WAS TO COMPARE THE EFFECTS OF COGNITIVE-BEHAVIORAL THERAPY (CBT) AND YOGA ON LATE-LIFE WORRY, ANXIETY, AND SLEEP; AND EXAMINE PREFERENCE AND SELECTION EFFECTS ON THESE OUTCOMES. OBJECTIVE: THE PRESENT ANALYSES COMPARED EFFECTS OF THE 2 INTERVENTIONS ON ADDITIONAL OUTCOMES (DEPRESSIVE SYMPTOMS, GENERALIZED ANXIETY SYMPTOMS, FATIGUE, PAIN INTERFERENCE/INTENSITY, PHYSICAL FUNCTION, SOCIAL PARTICIPATION); AND EXAMINED WHETHER THERE ARE PREFERENCE AND SELECTION EFFECTS FOR THESE TREATMENTS. METHODS: A RANDOMIZED PREFERENCE TRIAL OF CBT AND YOGA WAS CONDUCTED IN ADULTS >/=60 YEARS WHO SCORED >/=26 ON THE PENN STATE WORRY QUESTIONNAIRE-ABBREVIATED (PSWQ-A), RECRUITED FROM OUTPATIENT MEDICAL CLINICS, MAILINGS, AND ADVERTISEMENTS. COGNITIVE-BEHAVIORAL THERAPY CONSISTED OF 10 WEEKLY TELEPHONE SESSIONS. YOGA CONSISTED OF 20 BI-WEEKLY GROUP YOGA CLASSES. PARTICIPANTS WERE RANDOMIZED TO(1): A RANDOMIZED CONTROLLED TRIAL (RCT) OF CBT OR YOGA (N = 250); OR (2) A PREFERENCE TRIAL IN WHICH THEY SELECTED THEIR TREATMENT (CBT OR YOGA; N = 250). OUTCOMES WERE MEASURED AT BASELINE AND POST-INTERVENTION. RESULTS: WITHIN THE RCT, THERE WERE SIGNIFICANT BETWEEN-GROUP DIFFERENCES FOR BOTH PAIN INTERFERENCE AND INTENSITY. THE PAIN INTERFERENCE SCORE IMPROVED MORE FOR THE CBT GROUP COMPARED WITH THE YOGA GROUP [INTERVENTION EFFECT OF (MEAN (95% CI) = 2.5 (.5, 4.6), P = .02]. FOR THE PAIN INTENSITY SCORE, THE INTERVENTION EFFECT ALSO FAVORED CBT OVER YOGA [.7 (.2, 1.3), P < .01]. DEPRESSIVE SYMPTOMS, GENERALIZED ANXIETY, AND FATIGUE SHOWED CLINICALLY MEANINGFUL WITHIN-GROUP CHANGES IN BOTH GROUPS. THERE WERE NO CHANGES IN OR DIFFERENCE BETWEEN PHYSICAL FUNCTION OR SOCIAL PARTICIPATION FOR EITHER GROUP. NO PREFERENCE OR SELECTION EFFECTS WERE FOUND. CONCLUSION: BOTH CBT AND YOGA MAY BE USEFUL FOR OLDER ADULTS FOR IMPROVING PSYCHOLOGICAL SYMPTOMS AND FATIGUE. COGNITIVE-BEHAVIORAL THERAPY MAY OFFER EVEN GREATER BENEFIT THAN YOGA FOR DECREASING PAIN. 2022 20 2644 33 YOGA FOR WOMEN WITH URGENCY URINARY INCONTINENCE: A PILOT STUDY. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE THE FEASIBILITY OF A GENTLE YOGA PROGRAM FOR WOMEN WITH URGENCY URINARY INCONTINENCE (UUI). ALSO, THESE PRELIMINARY DATA CAN EVALUATE IF YOGA IMPROVES SYMPTOM BURDEN, QUALITY OF LIFE, AND INFLAMMATORY BIOMARKERS FOR WOMEN WITH UUI. METHODS: THIS PROSPECTIVE NONRANDOMIZED SINGLE-ARM PILOT STUDY EVALUATED THE EFFECTIVENESS OF A TWICE-WEEKLY, 8-WEEK GENTLE YOGA INTERVENTION TO REDUCE UUI SYMPTOM BURDEN. CHANGES IN SYMPTOM BURDEN WERE MEASURED USING THE PELVIC FLOOR DISTRESS INVENTORY 20. SECONDARY MEASURES INCLUDED QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, SLEEP, STRESS, ANXIETY, AND INFLAMMATORY BIOMARKERS. OUTCOMES WERE EVALUATED WITH PAIRED T TESTING. RESULTS: TWELVE WOMEN COMPLETED THE YOGA INTERVENTION WITH NO ADVERSE OUTCOMES NOTED. URGENCY SYMPTOM BURDEN WAS SIGNIFICANTLY IMPROVED AFTER THE INTERVENTION (P = 0.01), AND WOMEN REPORTED AN INCREASE IN QUALITY OF LIFE (P = 0.04) AFTER THE YOGA INTERVENTION. FOLLOWING THE YOGA INTERVENTION, THE MAJORITY OF WOMEN REPORTED SYMPTOMS AS "MUCH BETTER" (N = 4 [33%]) AND "A LITTLE BETTER" (N = 5 [42%]), WITH 3 WOMEN (25%) REPORTING "NO CHANGE." WOMEN ALSO REPORTED SIGNIFICANT REDUCTION IN DEPRESSIVE SYMPTOMS (P = 0.03) AND BETTER QUALITY OF SLEEP (P = 0.03). NO SIGNIFICANT CHANGES WERE FOUND IN ANXIETY OR STRESS PERCEPTION. PLASMA LEVELS OF THE INFLAMMATORY BIOMARKER TUMOR NECROSIS FACTOR ALPHA WERE REDUCED AFTER YOGA INTERVENTION (P = 0.009); HOWEVER, NO SIGNIFICANT POSTYOGA CHANGES WERE FOUND FOR INTERLEUKIN 6 OR C-REACTIVE PROTEIN. CONCLUSIONS: THIS STUDY PROVIDES PRELIMINARY EVIDENCE THAT YOGA IS A FEASIBLE COMPLEMENTARY THERAPY THAT REDUCES INCONTINENCE SYMPTOM BURDEN, ALONG WITH IMPROVING QUALITY OF LIFE, DEPRESSIVE SYMPTOMS, AND SLEEP QUALITY. ADDITIONALLY, YOGA MAY LOWER INFLAMMATORY BIOMARKERS ASSOCIATED WITH INCONTINENCE. 2021